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Mammalian golgins of the trans-Golgi network (TGN)
are small G protein effectors that are required for
membrane transport and contain a Golgi targeting
C-terminal GRIP domain. The localization of two
TGN golgins, p230/golgin-245 and golgin-97, is
mediated by the small GTPase Arl1, whereas recruit-
ment of the TGN golgin GCC185 is controversial.
Recently, GCC185 was proposed to localize to the
Golgi by the co-operation of two small GTPases,
Rab6A/A’ and Arl1 (Burguete et al., 2008), a model
based predominantly on in vitro interactions. Here
we demonstrate that Golgi recruitment of endoge-
nous GCC185 does not involve Rab6A/A’ and Arl1.
We find minimal colocalization between Rab6A/A’
and endogenous GCC185 on Golgi membranes and
failed to detect an interaction between Rab6A/A’
and C-terminal domains of GCC185 by yeast
two-hybrid analyses. Moreover, depletion of both
Rab6A/A’ and Arl1 also had no effect on the localiza-
tion of endogenous GCC185 or the isolated GRIP
domain of GCC185.
INTRODUCTION
Small G proteins and their effectors play key roles in regulating
membrane transport into and from the Golgi apparatus (Derby
and Gleeson, 2007; Gillingham and Munro, 2007; Pfeffer, 2007;
Short et al., 2005). One family of small G protein effectors that
are critical for several membrane transport pathways at the TGN
are golgins, large coiled-coil proteins recruited to the TGNby their
45 residue C-terminal GRIP domain (Barr, 1999; Gleeson et al.,
2004; Kjer-Nielsen et al., 1999a; Munro and Nichols, 1999). There
are four humanTGNgolgins, namely p230/golgin-245 (p230), gol-
gin-97, GCC185, and GCC88 (Erlich et al., 1996; Fritzler et al.,
1995; Gleeson et al., 1996; Griffith et al., 1997; Kooy et al., 1992;
Luke et al., 2003). Each TGN golgin is localized to a distinct sub-
domain of the TGN and appears to have independent functions
in membrane transport (Derby et al., 2004, 2007; Lieu et al.,
2007, 2008; Lock et al., 2005; Luke et al., 2003). Recruitment of
both p230/golgin-245 (p230) and golgin-97 to the TGN is medi-ated by the small GTPase Arl1, which binds to the GRIP domain
and specifies Golgi targeting (Gangi Setty et al., 2003; Jackson,
2003; Lu and Hong, 2003; Panic et al., 2003b).
GCC185 is essential for retrograde transport of Shiga toxin
and for Rab9-dependent transport from late endosomes to the
TGN (Derby et al., 2007; Reddy et al., 2006). In addition,
GCC185 associates with CLASP proteins that are required for
microtubule nucleation at the Golgi (Efimov et al., 2007).
GCC185 is located to a TGN domain distinct from the TGN gol-
gins p230 and golgin-97 (Derby et al., 2004). In contrast to p230
and golgin-97, GCC88 and GCC185 bind Arl1 very poorly and
appear to have different membrane-binding properties (Derby
et al., 2004; Lu and Hong, 2003; Reddy et al., 2006). In addition,
whereas an invariant tyrosine of theGRIP domain is important for
the interaction of p230/golgin-245 with Arl1, we and others have
shown that mutation of the invariant tyrosine residue hadminimal
effect on Golgi localization of GCC185 (Derby et al., 2007; Reddy
et al., 2006). Moreover, early endosome-targeted Arl1 does not
relocalize GCC185 (Derby et al., 2004). Recently, Burguete
et al. (2008) proposed that both Rab6 and Arl1 co-ordinate the
Golgi targeting of GCC185. Analysis of the interaction of
Rab6Awith polypeptide fragments ofGCC185 identified a helical
Rab6-binding domain N-terminal to the GRIP domain. The
crystal structure of a 66 residue polypeptide of GCC185 and
the GTP-bound mutant of Rab6A (Q72L) demonstrated a
complex of two Rab6 molecules interacting with a dimer of the
Rab-binding domain of GCC185 (Burguete et al., 2008). Further-
more the authors demonstrated that Rab6A enhanced the ability
of a 110 residue fragment of GCC185 to bind Arl1 in vitro. These
findings are particularly significant as they may demonstrate
a novel mechanism for the membrane recruitment of an effector
protein by the co-operation of two small GTPases.
A fundamental question arising from the work of Burguete
et al. (2008) is whether the interactions observed with the
GCC185 fragments in vitro reflect interactions that are relevant
to the localization of this TGN golgin in vivo. These authors did
not assess the behavior of endogenous GCC185 but rather
restricted their in vivo analyses toGCC185 constructs expressed
in transfected cells. One difficulty here is that overexpression of
full-length GCC185 is known to perturb the Golgi structure
(Derby et al., 2004). In addition, we and others have shown
that the C-terminal region of GCC185, containing the modestly
conserved GRIP domain but lacking the flanking putative Rab-
binding domain, is recruited to the Golgi in transfected cellsCell 138, 787–794, August 21, 2009 ª2009 Elsevier Inc. 787
Figure 1. Localization of Rab6 and GCC185 in HeLa Cells
(A) HeLa cells were transfected with GFP-Rab6A for 48 hr and fixed with 4% paraformaldehyde. Cells were stained with affinity-purified rabbit anti-GCC185
antibodies followed by Alexa 568-conjugated anti-rabbit IgG. Images were collected separately.
(B) Magnification of the boxed image in (A). The fluorescence intensity linescan profile was generated through the merged image and demonstrates the indepen-
dence of the two fluorescent populations. Bar = 10 mm.(Derby et al., 2004; Kjer-Nielsen et al., 1999a;Munro andNichols,
1999). Given these ambiguities we have further investigated the
role of Rab6 and Arl1 in the localization of endogenous GCC185.
Here we report that these small G proteins are not required for
the Golgi recruitment of endogenous GCC185.
RESULTS AND DISCUSSION
GCC185 Is Localized to a TGN Region Distinct
from Arl1 and Rab6
We have previously shown that there is very little colocalization
of GCC185 with Arl1 on Golgi membranes, in contrast to the
strong colocalization of Arl1 and golgin-97. This finding is consis-
tent with the proposal that GCC185 is localized to the Golgi by a
mechanism that is distinct from that used by golgin-97 and p230
(Derby et al., 2004). In view of the report by Burguete et al. (2008),
here we have extended these findings to determine the subdo-
main relationship between endogenous GCC185 and Rab6.
HeLa cells were transfected with GFP-Rab6A or GFP-Rab6A’
and transfected cells stained for endogenous GCC185. There
was only a low level of colocalization between either GFP-
Rab6A (Figure 1) or GFP-Rab6A’ (not shown) and endogenous
GCC185, although both molecules were found in close physical788 Cell 138, 787–794, August 21, 2009 ª2009 Elsevier Inc.proximity to each other in the juxtanuclear region of the cell.
Furthermore, use of fixation conditions to allow membrane
tubules to be visualized by immunofluorescence identified
GFP-Rab6A-labeled tubules arising from the Golgi region that
showed no costaining for endogenous GCC185 (not shown).
These results indicate that the majority of GCC185 molecules
are located to a region of the TGN distinct from Rab6.
Depletion of Rab6 and Arl1 Does Not Affect GCC185
Localization
In view of the reported interactions of Rab6 and Arl1 with poly-
peptide fragments of GCC185 in vitro (Burguete et al., 2008),
next we directly assessed whether these Golgi-localized small
GTPases are responsible for membrane recruitment of endoge-
nous GCC185. Two isoforms of Rab6, corresponding to splice
variants of the same gene, are present in HeLa cells, Rab6A
and Rab6A’ (Del Nery et al., 2006). Rab6A and RabA’ were either
individually silenced using specific siRNA targets or simulta-
neously silenced using an siRNA target for both Rab6A and
Rab6A’ (Del Nery et al., 2006). The outcome was identical in
both cases, and therefore we show only the results from the
experiments using the siRNA that targets both Rab6A and
RabA’. Very little Rab6 could be detected by confocal
microscopy in HeLa cells transfected with the Rab6A/A’ siRNA
target sequence. The images presented in Figure 2 are represen-
tative of five separate transfections. Whereas 100% of control
cells had detectable Rab6 by confocal microscopy, the majority
(at least 80%) of siRNA-transfected cells showed little or no
Rab6 staining, using an antibody that recognizes both Rab6A
splice variants. Measurement of fluorescent intensity on a cell
basis revealed that the majority of cells had <5% of the level of
Rab6 compared with control cells. To quantify Rab6A/6A’ deple-
tion in the cell population, siRNA-transfected cells were analyzed
Figure 2. Depletion of Rab6 and Arl1 Has No Effect
on the Location of Endogenous GCC185
HeLa cells were either untreated (control) or transfected
withRab6A/Rab6A’ siRNAfor72hr, fixed in4%paraformal-
dehyde,and (A) stainedwith rabbit anti-Rab6antibodies fol-
lowed by Alexa 488-conjugated anti-rabbit IgG and mono-
clonal mouse anti-GM130 antibodies followed by Alexa
568-conjugated anti-mouse IgG or (B) stained with rabbit
anti-GCC185 antibodies followed by Alexa 488-conjugated
anti-rabbit IgG and monoclonal mouse anti-GM130 anti-
bodies followed by Alexa 568-conjugated anti-mouse IgG.
Nuclei were stained with DAPI. In (A) and (B), bar = 10 mm.
(C) HeLa cells were lysed in SDS-PAGE reducing buffer
and extracts resolved on a 4%–12% NuPAGE gel.
Proteins were transfered to a PVDF membrane and
probedwith rabbit anti-Rab6 antibodies and anti-a-tubulin
antibodies using a chemiluminescence detection system.
The membranes were then stripped and reprobed with
anti-GCC185 antibodies.
by immunoblotting (Figure 2B). Based on densi-
tometry analysis, standardized to a-tubulin
staining, the 23 kDa Rab6 was depleted in
the population of siRNA-transfected cells by
80%. Endogenous GCC185 was detected in
these siRNA-treated cells using an affinity-puri-
fied rabbit antibody. Significantly, endogenous
GCC185 remained Golgi localized in all the
Rab6-depleted cells (>100 cells analyzed).
Measurement of fluorescent intensity of control
and Rab6 siRNA-transfected cells revealed no
difference in the level of endogenous GCC185
at the Golgi (not shown).
To confirm that the ablation of Rab6A/A’ in
these experiments resulted in a loss of Rab6
function, we analyzed the retrograde transport
of Shiga toxin fragment B (STx-B) in Rab6-
depleted cells, as Rab6 is essential for the trans-
port of this toxin from endosomes to the TGN
(Mallard et al., 2002). STx-B was bound to the
surface of transfected HeLa cells at 0C and
the trafficking of surface-bound Shiga toxin
followed at 37C for 90 min. In control cells,
the majority of STx-B was found in the Golgi
region by 90 min, as expected, whereas in
Rab6-depleted cells STx-B was predominantly
located in endosomal structures, indicating a
block in retrograde transport from endosomes
to the Golgi (Figure S1 available online). These data show that
the silencing of Rab6 was effective. Moreover, as there was no
reduction of Golgi-localized GCC185 in Rab6-depleted cells,
overall these results suggest that Rab6A/A’ is not involved in
the membrane recruitment of this TGN golgin.
The silencing of Arl1 also had no effect on the localization of
endogenous GCC185. Whereas Arl1 siRNA-transfected cells
showed a loss of Golgi-localized golgin-97 and p230, as ex-
pected and confirming the absence of Arl1 (Lu and Hong,
2003), there was no reduction in the level of endogenousCell 138, 787–794, August 21, 2009 ª2009 Elsevier Inc. 789
GCC185 (Figure S2), confirming the previous conclusion that
Arl1 is not required for GCC185 localization (Derby et al., 2004).
In view of the model proposed by Burguete et al. (2008) sug-
gesting a dual GTPase membrane attachment of GCC185, we
next determined whether the silencing of both Rab6A/6A’ and
Arl1 influenced GCC185 localization. In cells depleted of both
small G proteins, there was no apparent reduction of GCC185
in the Golgi region (not shown). In the double knockdown exper-
iments, 80% of the cell population was efficiently depleted of
Rab6 and 80% of cells showed a loss of Golgi-localized golgin-
97 and p230, indicative of Arl1 depletion. All cells examined
(>100) showed normal levels of Golgi-localized GCC185, based
onmeasurement of fluorescence intensity. These results indicate
that the steady-state localization of endogenous GCC185 to
Golgi membranes in HeLa cells is independent of Rab6 and Arl1.
Rab6 and Arl1 Are Not Required for Recruitment
of Cytosolic GCC185 to Golgi Membranes
It is formally possible that the Golgi recruitment of soluble
GCC185 requires Rab6 and Arl1 and, after membrane attach-
Figure 3. Endogenous GCC185 Is Recruited
from the Cytosol to Golgi Membranes following
Washout of BFA in Rab6- and Arl1-Depleted
Cells
HeLa cells were either untransfected (control) or
transfected with Rab6A/Rab6A’ siRNA, Arl1 siRNA,
or siRNAs to both Rab6A/Rab6A’ and Arl1 for 72 hr
and incubated with 5 mg/ml BFA at 37C for 45 min.
Cells were fixed either immediately or after a 3.5 hr
BFA washout and stained with rabbit anti-GCC185
antibodies followed by Alexa 488-conjugated anti-
rabbit IgG and monoclonal mouse anti-GM130 anti-
bodies followed by Alexa 568-conjugated anti-mouse
IgG. Bar = 10 mm.
ment, GCC185 then is stabilized by other
interactions. The experiments above were
performed 72 hr after transfection with
siRNA, which should be sufficient time for
the recycling of endogenous full-length
GCC185 between the cytosol and mem-
branes. Nonetheless, to establish whether
Rab6 and/or Arl1 are directly required for
recruitment of GCC185 from the cytosol to
membranes, we treated cells with brefeldin
A (BFA) for 45 min to dissociate the pool of
membrane-bound golgin and then washed
out BFA and monitored the recruitment of
cytosolic GCC185 back toGolgi membranes
(Figure 3). GCC185was dissociated from the
Golgi in the presence of BFA and in the
absence of Rab6A/6A’ and/or Arl1 was effi-
ciently recruited to Golgi membranes after
a 3.5 hr washout of the drug. In the majority
(70%–80%) of the 100 cells analyzed for
each sample, GCC185 was recruited back
to the Golgi region after BFA washout,
regardless of the absence of Rab6 or Arl1,
or both Rab6/Arl1 (Figure 3). The fact that the remaining 20%–
30% of treated cells did not show GCC185 recruitment to the
juxtanuclear region is likely due to the absence of a reformed
Golgi after the BFA washout as these cells also did not stain
for the cis-Golgi marker GM130. Thus, this experiment directly
demonstrates that the binding of the soluble GCC185 from the
cytosol to Golgi membranes is independent of these two small
GTPases.
Golgi Targeting of the C-Terminal Domains of GCC185
Is Independent of Rab6 and Arl1
We have previously demonstrated that the C-terminal 82 residue
fragment of GCC185 (GRIP domain) is Golgi localized in cells
transfected with a GFP fusion construct (GFP-GCC185GRIP).
This C-terminal 82 residue fragment does not contain the puta-
tive Rab-binding domain identified by Burguete et al. (2008).
To explore the behavior of a longer polypeptide fragment
of GCC185, we constructed a GFP fusion protein comprising
the C-terminal 200 residues of GCC185 (aa 1485–1684)
and including approximately 60 residues of coiled-coil sequence790 Cell 138, 787–794, August 21, 2009 ª2009 Elsevier Inc.
upstream from the GRIP domain, including the putative Rab-
binding domain. GFP-GCC185C200 was concentrated in the
Golgi region and colocalized with TGN markers (Figure 4B).
Comparison of GFP-GCC185C200 and GFP-GCC185GRIP at simi-
lar levels of expression showed that GCC185C200 was predomi-
nantly Golgi localized in transfected cells whereas GCC185GRIP
was localized to the Golgi as well as detected in the cytoplasm
(Figure 4A). We have previously reported that the inclusion of
sequences flanking the GRIP domain of p230/golgin-245
enhances the efficiency of Golgi localization in transfected cells
(Kjer-Nielsen et al., 1999b) and is likely to be due to the stabiliza-
tion of the dimeric structure of the golgin fragments (Luke et al.,
2005; Panic et al., 2003a; Wu et al., 2004). It is possible that the
more efficient Golgi localization of GCC185C200 compared with
GCC185GRIP is also due to the stabilization of a dimeric structure.
Figure 4. Depletion of Rab6 and Arl1 Has No Effect on the
Golgi Targeting of the C-Terminal Domain of GCC185
HeLa cells were transfected with either Rab6A/Rab6A’ siRNA or
siRNAs to both Rab6A/Rab6A’ and Arl1 for 48 hr then transfected
again with either (A) GFP-GCC185GRIP or (B) GFP-GCC185c200.
After a further 24 hr, cells were fixed and permeabilized, then
stained for p230 with human anti-p230 antibodies followed by
Alexa 568-conjugated anti-human IgG and for Rab6 with rabbit
anti-Rab6 antibodies followed by Alexa 647-conjugated anti-
rabbit IgG. Nuclei were stained with DAPI. Bars = 10 mm.
At high levels of expression the GCC185C200 construct
perturbed the structure of the Golgi (not shown),
whereas this was not the case with the GCC185GRIP
construct that lacked coiled-coil sequences. Regard-
less, these data demonstrate that the C-terminal
GRIP domain of GCC185, without the purported
Rab-binding domain, is Golgi localized.
The intracellular location of GFP-GCC185GRIP and
GFP-GCC185C200 was analyzed in Rab6- and Arl1-
depleted cells. The absence of Rab6A/6A’, Arl1, or
both Rab6/Arl1 simultaneously had no effect on
the localization of either GFP-GCC185GRIP or GFP-
GCC185C200 (Figure 4). For example, quantitative
analysis showed that >90% of cells expressing low-
medium levels of GFP-GCC185C200 were Golgi local-
ized in the absence of Rab6. Likewise >90% of cells
expressing low-medium levels of GCC185GRIP were
Golgi localized regardless of the presence or absence
of either Rab6 or Arl1.
In view of the above results we also examined an
identical C-terminal construct reported by Burguette
et al., namely a myc-tagged C-terminal 110 residue
fragment of GCC185 (myc-GCC185C110), which
includes the putative Rab6-binding domain. At low
levels of expression myc-GCC185C110 was concen-
trated in the Golgi region and colocalized with TGN
markers; however, at medium to high levels of expres-
sion myc-GCC185C110 dramatically perturbed the
structure of the Golgi, in a similar fashion as the
C-200 construct (data not shown). As for GFP-
GCC185C200, the Golgi location of myc-GCC185C110
was not affected by the absence of Rab6A/6A’ or Arl1 or both
simultaneously (Figure S3).
Finally, we assessed by yeast two-hybrid assays the capacity
of the three C-terminal constructs of GCC185 (C-82, C-110,
and C-200) to interact with Rab6. Neither C-200, C-110, nor
C-82 showed a significant interaction with either Rab6A or
Rab6A’ (Table S1). The pLEX-Rab6A/A’ constructs used in this
analysis interact with all known Rab6 effectors (data not shown).
It should be pointed out that C-200, but not C-110, bound to
Rab6B (GTP), an interaction also recently reported for a C-termi-
nal 343 residue fragment of GCC185 (Hayes et al., 2009). In
contrast to Rab6A/A’ whose expression is ubiquitous, Rab6B is
encoded by a separate gene and is specifically expressed in
neuronal tissues and cells (Opdam et al., 2000). Its exact function
is currently unknown. The lack of an interaction of eitherCell 138, 787–794, August 21, 2009 ª2009 Elsevier Inc. 791
GCC185C-200 or GCC185C-110 with Rab6A/A’ in the yeast two-
hybrid assay throws into question the relevance of the Rab6A
interaction detected in in vitro assays (Burguete et al., 2008).
Recently, Munro and colleagues have mapped the Rab-binding
sites of the Drosophila orthologs of the GRIP domain golgins
and also did not detect Rab6 binding to the C-terminal region
of the Drosophila GCC185 (Sinka et al., 2008).
Overall, these analyses show that Rab6A/A’ and Arl1 do not
play a role in the localization of endogenous GCC185. Our
study highlights the importance of analyzing the behavior of
endogenous molecules. Mutation of the Rab-binding domain
(I1588A/L1595A) in full-length GCC185 was reported to abolish
Golgi localization (Burguete et al., 2008). However, it is not
clear what impact the I1588A/L1595A mutation has on the
structure and stability of full-length GCC185 in transfected
cells. Also the impact of expression of the full-length molecule
on the structure of the Golgi does not appear to have been
considered in the study by Burguete et al. (2008), but this is
a relevant issue because exogenous expression of a number
of full-length golgins, including GCC185, can greatly perturb
the structure of the TGN (Derby et al., 2004; Gleeson et al.,
2004; Luke et al., 2003). The interaction between GTP-bound
Rab6 and the 66 residues of coiled-coil sequence of GCC185
is of reasonable affinity (Burguete et al., 2008); however, the
data from the yeast two-hybrid interaction suggest that
GCC185 and Rab6 may not interact in vivo. Hence the physio-
logical significance of this in vitro interaction is uncertain.
Recent studies from the Pfeffer and Munro laboratories have
shown that the coiled-coil regions of the TGN golgins contain
multiple binding sites for Rab proteins (Hayes et al., 2009;
Sinka et al., 2008). The findings by these authors raise the
possibility that Rab interactions with TGN golgins play a critical
role in mediating the specific functions of the TGN golgins
associated with membrane transport. Notwithstanding the
importance of these findings in understanding the effector
functions of GCC185, the data presented in this manuscript
clearly indicate that Rab6 does not contribute to the Golgi
localization of GCC185. Although the membrane recruitment
of GCC185 is dependent on small GTP-binding proteins, the
identity of the interacting G protein(s) responsible for TGN
localization remains unclear.
EXPERIMENTAL PROCEDURES
Antibodies
Rabbit polyclonal antibodies to human GCC88 and GCC185 have been
described (Luke et al., 2003). Rabbit antibodies to GCC185 were affinity-puri-
fied on a column of GST-GCC185GRIP fusion protein. Human autoantibodies to
p230 and affinity-purified rabbit antibodies to p230 are as described (Kooy
et al., 1992). Rabbit antibodies to human Rab6 (C-19) were purchased from
Santa Cruz Biotechnology Inc (Santa Cruz, CA, USA). Monoclonal antibodies
to GM130 and human golgin-97 were from BD Biosciences (NSW, Australia).
Mouse monoclonal anti-a-tubulin was obtained from GE Healthcare (Rydal-
mere, NSW, Australia). Secondary antibodies for immunofluorescence were
goat anti-rabbit IgG-Alexa Fluor 488, goat anti-rabbit IgG-Alexa Fluor 568,
goat anti-rabbit IgG-Alexa Fluor 647, goat anti-mouse IgG Alexa Fluor
488, goat anti-mouse IgG Alexa Fluor 647, and goat anti-human Alexa Fluor
568 purchased fromMolecular Probes (Invitrogen, Carlsbad, CA USA). Horse-
radish peroxidase-conjugated sheep anti-rabbit Ig and anti-mouse Ig were
from DAKO Corporation (Carpinteria, CA, USA).792 Cell 138, 787–794, August 21, 2009 ª2009 Elsevier Inc.Constructs
Aconstruct containing theC-terminal 82 amino acids of GCC185 (residue 1603
to 1684) fused to GFP (GFP-GCC185GRIP) has been described (Luke et al.,
2005). The sequence encoding the C-terminal 200 amino acids of GCC185
(residues 1485–1684) was amplified from pBluescript-SK+ - KIAA0336
(provided by Kazusa DNA Research Institute, Kisarazu, Chiba, Japan) using
the primers 50-CCGGAATTCCGTTTCCTCTCAACAATCT-30 and 50-CCGGAA
TTCCTATCGAAGTCCAGACCA-30. The PCRproduct was digested with EcoRI
and cloned into the EcoRI site of pEGFP-C1 (GFP-GCC185C200). GFP-Rab6A
and GFP-Rab6A’ were generated as described (White et al., 1999). Myc-
tagged construct containing the C-terminal 110 amino acids of GCC185 was
generated as described (Burguete et al., 2008).
RNA Interference
siRNA sequences that individually target human Rab6A and Rab6A’, an siRNA
sequence that targets both Rab6A and Rab6A’ splice variants (Del Nery et al.,
2006), and an siRNA sequence to target Arl1 and control siRNA (Lu and Hong,
2003) have been previously described. siRNA duplexes were synthesized by
Sigma Proligo (Lismore, Australia).
Yeast Two-Hybrid Assays
Rab6 constructs were cloned into the polylinker sites of the pLexA vector and
GCC185 domains cloned into the pGAD vector, and yeast two-hybrid assays
were performed as previously described (Janoueix-Lerosey and Goud, 2000).
Cell Culture and Transfection
HeLa cells were maintained as semi-confluent monolayers in Dulbecco’s
Modified Eagle’s media (DMEM) supplemented with 10% (v/v) fetal bovine
serum (FBS), 2 mM L-glutamine, 100 units/ml penicillin, and 0.1% (w/v) strep-
tomycin (C-DMEM) in a humidified 10% CO2 atmosphere at 37
C. Transient
transfections of fusion protein constructs were performed using FuGENE6
transfection reagent (Roche, Basel, Switzerland). Transfected cells were
cultured for 24–72 hr. Transfections with siRNA were performed using Oligo-
fectamine (Invitrogen), according to manufacturer’s instruction, for 72 hr prior
to analysis.
Immunofluorescence
Cells on coverslips were fixed in either 4% paraformaldehyde (PFA) for 15 min
or, for anti-p230 and anti-golgin-97 antibodies, methanol (20C) for 5 min,
free aldehyde groups quenched in 50 mM NH4Cl/PBS for 10 min and cells
permeabilized with 0.1% Triton X-100 in PBS for 4 min. Monolayers were
incubated in 5% FBS in PBS for at least 15 min to reduce nonspecific staining.
Monolayers were incubated with primary antibody, diluted in 5%FBS/PBS, for
45 min, washed in PBS, then incubated with secondary conjugated antibodies
for 30 min. Nuclei were stained with 40,6-Diamidino-2-phenylindole dihydro-
chloride (DAPI) (Sigma-Aldrich, St. Louis, MO, USA) diluted to 1 mg/ml for
5 min, washed with PBS, then rinsed briefly in water. Coverslips were then
blotted dry and mounted in mowiol on a microscope slide.
To preserve membrane tubules, cells were fixed with 2% PFA in complete
DMEM for 15 min at room temperature, then 4% PFA in PBS for 30 min at
room temperature, then they were processed as described above.
Brefeldin A Treatment and Washout
Transfected cells were treatedwith 5 mg/ml brefeldin A (BFA) (Calbiochem, San
Diego, CA, USA) diluted in serum-free DMEM at 37C for 45 min. Cells were
either fixed immediately in 4% PFA or washed with serum-free DMEM and
incubated at 37C in complete medium for 3.5 hr to allow the cells to recover
in the absence of the drug. Washed-out cells were fixed in 4% PFA and pro-
cessed for immunofluorescence.
Confocal Microscopy and Image Analysis
All images were acquired using a confocal laser scanning microsope (Leica
LCS SP2 confocal imaging system) using a 1003/1.4 NA HCX PL APO CS
oil immersion objective. GFP and Alexa 488 were excited with the 488 nm
line of an Argon laser, Alexa 568 with a 543 nm HeNe laser, Alexa 647 with
a 633 nmHeNe laser, and DAPI with a 405 nmUV laser. For multicolor labeling,
images were collected independently. Quantitation of fluorescence intensity
was assessed with the LCS Quantify option. Images were cropped in Photo-
shop. Scale bars represent 10 mm.
Immunoblotting
Transfected HeLa cells were lysed in SDS-loading buffer. Extracts were
resolved on SDS-PAGE 4%–12% NuPAGE gels. Proteins were transferred
to PVDF membrane, then probed with rabbit anti-GCC185, rabbit anti-Rab6,
or mouse anti-a-tubulin antibodies, diluted in 1% BSA/PBS for 1 hr, and
washed three times, each 10 min, in 0.1% Tween20/PBS. The PVDF
membrane was then incubated with horseradish peroxidase-conjugated
anti-mouse or anti-rabbit antibodies, diluted in 1% BSA/PBS for 1 hr, and
washed three times in 0.1% Tween20/PBS. Bound antibodies were detected
by enhanced chemiluminescence (NEN, Boston, MA USA). Membranes were
stripped with 25 mM glycine-HCl, pH 2, 1% (w/v) SDS in PBS then reprobed
with a primary antibody. Images were captured and analyzed using the Gel
Proanalyzer program (Media Cybernetics, Bethesda, MD, USA).
Internalization Assays
For Shiga toxin internalization assays, Cy3-conjugated Shiga toxin fragment B
(STx-B) (Mallard et al., 1998) was bound on ice for 45 min, and cells washed
and then internalized continuously at 37C as previously described (Lieu
et al., 2007).
SUPPLEMENTAL DATA
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